VOC VOC Energy Trust
- 5.770
- +0.030+0.52%
- 5.710
- -0.060-1.04%
VOC Energy Trust News
VOC Energy Trust | 10-Q: Quarterly report
VOC Energy Trust Dividend Declines by 5.3% to $0.18
VOC Energy Trust To Go Ex-Dividend On April 29th, 2024 With 0.18 USD Dividend Per Share
April 19th - $VOC Energy Trust(VOC.US)$ is trading ex-dividend on April 29th, 2024. Shareholders of record on April 30th, 2024 will receive 0.18 USD dividend per share on May 15th, 2024. The ex-di
VOC Energy Trust Files 2023 Annual Report on Form 10-K
Oil giant executives warn: Red Sea crisis could push oil prices above $90
At least two vessels transporting fuel from Kuwait to Europe were rerouted after an attack on a Tock Group tanker.
VOC Energy Trust Cuts Dividend by About 16% $0.19 a Share
VOC Energy Trust To Go Ex-Dividend On January 29th, 2024 With 0.19 USD Dividend Per Share
January 20th - $VOC Energy Trust(VOC.US)$ is trading ex-dividend on January 29th, 2024. Shareholders of record on January 30th, 2024 will receive 0.19 USD dividend per share on February 14th, 2024
VOC Energy Trust: Winter Storms in Kansas, Texas Cut Into Oil Production
By Mary de Wet VOC Energy Trust reduced its distribution of profits to unitholders and warned of lower payouts in the first quarter of 2024 after severe winter storms in Kansas and Texas affected oil
Press Release: VOC Energy Trust Announces Trust Quarterly Distribution
VOC Energy Trust Announces Trust Quarterly Distribution HOUSTON--(BUSINESS WIRE)--January 19, 2024-- VOC Energy Trust (NYSE: VOC) announced the Trust distribution of net profits for the quarterly pa
FDA Approves First Gene Therapies to Treat Patients With Sickle Cell Disease
Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signaling an innovative advancement in the field of gene therapy. Sickle cell disease is a group of inherited blood disorders affecting approximately 100,000 people in the U.S. It is most common in African Americans and, while less prevalent, also affects Hispanic Americans. The primary problem in sickle cell disease is a mutation ...
VOC Energy Trust's Dividend Analysis
VOC Energy Trust Raises Dividend by 7.1% to $0.225
VOC Energy Trust To Go Ex-Dividend On October 27th, 2023 With 0.225 USD Dividend Per Share
October 20th - $VOC Energy Trust(VOC.US)$ is trading ex-dividend on October 27th, 2023. Shareholders of record on October 30th, 2023 will receive 0.225 USD dividend per share on November 14th, 202
VOC Energy Trust Declares $0.21 Dividend
VOC Energy Trust To Go Ex-Dividend On July 28th, 2023 With 0.21 USD Dividend Per Share
July 21st - $VOC Energy Trust(VOC.US)$ is trading ex-dividend on July 28th, 2023. Shareholders of record on July 31st, 2023 will receive 0.21 USD dividend per share on August 14th, 2023. The ex-di
Intercontinental Hotels Group And 4 Other Stocks Have Very High Payout Ratio
(VIANEWS) – Plains Group Holdings, L.P. (PAGP), VOC Energy Trust Units of Beneficial Interest (VOC), Intercontinental Hotels Group (IHG) are the highest payout ratio stocks on this list.
BP to Pay Record $40M Settlement in Whiting Refinery Pollution Charges
VOC Energy Trust To Go Ex-Dividend On April 28th, 2023 With 0.23 USD Dividend Per Share
April 27th - $VOC Energy Trust(VOC.US)$ is trading ex-dividend on April 28th, 2023. Shareholders of record on May 1st, 2023 will receive 0.23 USD dividend per share on May 12th, 2023. The ex-divid
VOC Energy Trust (NYSE:VOC) to Issue $0.23 Dividend
VOC Energy Trust (NYSE:VOC – Get Rating) declared a dividend on Saturday, April 22nd, investing.com reports. Shareholders of record on Monday, May 1st will be paid a dividend of 0.23 per share by the
VOC Energy Trust Declares $0.23 Dividend
Analysis
Price Target
No Data
